Ritter Pharmaceuticals, Inc. announced it has appointed William Merino, Ph.D., to its Board of Directors. Dr. Merino will occupy a newly-created seat, advising on regulatory, clinical and related strategies. Dr. Merino has over 30 years of global experience in drug and device registration. He has worked extensively with senior members of the U.S. Food and Drug Administration as well as many international regulatory authorities. Dr. Merino has previously served as a Senior Clinical and Regulatory advisor to the Company providing considerable guidance.